title: Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products.
abstract: It is well-known that probiotics have a number of beneficial health effects in humans and animals, including the reduction of symptoms in lactose intolerance and enhancement of the bioavailability of nutrients. Probiotics have showed to possess antimutagenic, anticarcinogenic and hypocholesterolemic properties. Further, they were also observed to have antagonistic actions against intestinal and food-borne pathogens, to decrease the prevalence of allergies in susceptible individuals and to have immunomodulatory effects. Typically, the bacteria colonise the intestinal tract first and then reinforce the host defence systems by inducing a generalised mucosal immune response, balanced T-helper cell response, self-limited inflammatory response and secretion of polymeric IgA. Scientific reports showed that the Taiwan native lactic acid bacterium from newborn infant faeces identified as Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products proved to be effective for the management of blood cholesterol and pressure, prevention of gastric mucosal lesion development, immunomodulation and alleviation of allergies, anti-osteoporosis and inhibition the fat tissue accumulation. This review article describes that the beneficial effects of this Lactobacillus strains and derivative products may be suitable for human and animals.
authors.affiliation: Department of Food Science and Biotechnology, College of Agriculture and Natural Resources, National Chung Hsing University, 250 Kuo Kuang Rd., Taichung, Taiwan, Republic of China.
authors.forename: Shen-Shih
authors.initials: SS
authors.lastname: Chiang
authors.forename: Tzu-Ming
authors.initials: TM
authors.lastname: Pan
mesh_terms: D000818:Animals; D006224:Cricetinae; D005260:Female; D005285:Fermentation; D005767:Gastrointestinal Diseases / Q000276:immunology / Q000628:therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy; D018928:Immunity, Mucosal / Q000276:immunology; D007231:Infant, Newborn; D007778:Lactobacillus / Q000276:immunology / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009765:Obesity / Q000628:therapy; D010024:Osteoporosis / Q000628:therapy; D019936:Probiotics / Q000378:metabolism* / Q000627:therapeutic use*; D051381:Rats; D013624:Taiwan